Phillips 66 Stock: Maintain Buy Recommendation Following Solid Q2 Results (NYSE:PSX)

ivanastar Investment Thesis Phillips 66 (NYSE:PSX) released solid Q2 results last week, beating the market estimates in several financial metrics. Despite the stock’s recent rally in the last couple of months, I believe PSX still demonstrates good value for a long-term play, whilst also satisfying income investors thanks to their favorable dividend yield relative to…

Read More

AT&T Stock: When Boring Implies A Stagnation (NYSE:T)

Anne Czichos In the past couple of months I have digged deep to provide you with my analysis and views on AT&T’s (NYSE:T) dividend play and the Company’s growth prospects to potentially capture some incremental gains from price appreciation on top of the ~8% yielding dividend. In the article “Demystifying The Sustainability Of AT&T’s Dividend”…

Read More

MarineMax: Sailing Through Market Cycles With Resilient Growth (NYSE:HZO)

BrooksElliott Introduction As margins are close to have returned to normal levels after a significant surge in demand from 2020 until early 2022, the valuations of MarineMax (NYSE:HZO) have undergone a substantial contraction. This has created an attractive margin of safety, indicating potential undervaluation. Despite the market’s overly pessimistic outlook, I believe the company’s earnings…

Read More

ReShape Lifesciences Inc. (RSLS) Q2 2023 Earnings Call Transcript

ReShape Lifesciences Inc. (NASDAQ:RSLS) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET Company Participants Michael Miller – Rx Communications, IR Paul Hickey – President and CEO Tom Stankovich – CFO Christine Ren-Fielding – Member, ReShape Scientific Advisory Board Conference Call Participants Anthony Vendetti – Maxim Operator Good afternoon, and thank you for…

Read More

Li Auto: The Underdog Disrupting The EV Market (NASDAQ:LI)

martin-dm Investment Thesis Since its foundation in 2015, Li Auto (NASDAQ:LI) has swiftly positioned itself as a leader in the Chinese EV market. The company adopts a unique approach to tackling range anxiety and charging inconvenience through ‘range extenders’, which are small gasoline engines that generate electricity to power its SUV’s battery when an EV…

Read More

BlackRock Stock: Signs Point To Caution Ahead (NYSE:BLK)

georgeclerk BlackRock (NYSE:BLK), one of the world’s best asset management companies, has been an excellent investment over most time frames as the chart below demonstrates. Seeking Alpha BlackRock stands tall as a global leader, offering an extensive range of investment products and services that cater to a diverse clientele, spanning from individual investors to institutional…

Read More

Paymentus Holdings, Inc. (PAY) Q2 2023 Earnings Call Transcript

Paymentus Holdings, Inc. (NYSE:PAY) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET Company Participants David Hanover – Investor Relations Dushyant Sharma – Founder and Chief Executive Officer Sanjay Kalra – Senior Vice President and Chief Financial Officer Conference Call Participants David Koning – Baird Ashwin Shirvaikar – Citi John Davis – Raymond…

Read More

Revenue Upside In 2023 Appears Limited For Information Services Group (NASDAQ:III)

Phiromya Intawongpan A Quick Take On Information Services Group Information Services Group, Inc. (NASDAQ:III) reported its Q2 2023 financial results on August 3, 2023, beating both expected revenue and EPS estimates. The company provides digital transformation consulting and technology services worldwide. I previously wrote about ISG with a Buy outlook. Forward revenue growth expectations are…

Read More

Red Violet, Inc. (RDVT) Q2 2023 Earnings Call Transcript

Red Violet, Inc. (NASDAQ:RDVT) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ET Company Participants Camilo Ramirez – Vice President, Finance & Investor Relations Derek Dubner – Chairman & Chief Executive Officer Dan MacLachlan – Chief Financial Officer Conference Call Participants Operator Good day ladies and gentlemen, and welcome to Red Violet’s Second…

Read More

Cara Therapeutics, Inc. (CARA) Q2 2023 Earnings Call Transcript

Cara Therapeutics, Inc. (NASDAQ:CARA) Q2 2023 Earnings Conference Call August 7, 2023 4:30 PM ET Company Participants Matthew Murphy – Manager, IR Christopher Posner – President, CEO & Director Ryan Maynard – CFO Scott Terrillion – Chief Compliance Officer, General Counsel & Corporate Secretary Conference Call Participants Dennis Ding – Jefferies Annabel Samimy – Stifel,…

Read More

DEM: This Decent-Yielding Fund Has Opted For The Right Emerging Markets

Pgiam/iStock via Getty Images ~ by Snehasish Chaudhuri, MBA (Finance). WisdomTree Emerging Markets High Dividend Fund ETF (NYSEARCA:DEM) is an emerging market exchange-traded fund, or ETF, that was launched on July 13, 2007, by WisdomTree Investments, Inc. The fund is co-managed by WisdomTree Asset Management, Inc. and Mellon Investments Corporation. It invests in high dividend…

Read More

Bloom Energy: Outlook Could Prove Aggressive Following Disappointing Q2 Results (NYSE:BE)

Sundry Photography I have previously covered Bloom Energy Corporation (NYSE:BE), so investors should view this as an update to my earlier articles on the company. Last week, leading stationary power generation system provider Bloom Energy Corporation reported mediocre second quarter results, with revenues and earnings per share coming in below consensus expectations: Company Presentation While…

Read More

BSTZ: A Solid Fund, But Timing Is A Question (NYSE:BSTZ)

Jonathan Kitchen Timing is everything. – Molly Sims. The BlackRock Science and Technology Term Trust (NYSE:BSTZ) commenced operations with a focus on equity securities issued by U.S. and non-U.S. science and technology companies across all market capitalization ranges. These companies are selected for their potential for rapid and sustainable growth, driven by the development, advancement,…

Read More

The 1-Minute Market Report August 5, 2023

coffeekai/iStock via Getty Images Originally posted on August 5, 2023 In this week’s issue of the 1-Minute Market Report, I examine the asset classes, sectors, equity groups, ETFs, and stocks that led the market lower, and which market segments bucked the trend by moving up. By keeping an eye on the leaders and laggards, we…

Read More

XLI: Industrial Fundamentals Look Great And It’s Time To Buy (NYSEARCA:XLI)

yucelyilmaz Investment Thesis Picking one sector to outperform is challenging. However, large-cap Industrial stocks, represented by the Industrial Select Sector SPDR ETF (NYSEARCA:XLI), look promising on paper, offering a relatively attractive 22.42x forward earnings valuation and 11.20% estimated earnings per share growth. In addition, XLI constituents delivered a solid earnings surprise this quarter, led by…

Read More

Wall Street Lunch: Office Ordeals

zoranm Listen below or on the go on Apple Podcasts and Spotify HSBC plans to move its global HQ to a smaller space as office real estate continues to struggle. (0:15) Nearly half of Americans would try weight loss pills. (2:52) Morgan Stanley shakes up its dividend stock poftfolio. (4:20) This is an abridged transcript…

Read More

Amgen Is Back! (NASDAQ:AMGN) | Seeking Alpha

Grand Warszawski Introduction Amgen (NASDAQ:AMGN) is back. After writing an article titled Amgen: A Healthcare Bargain With A 4% Yield in June, the stock has added 11%, beating the S&P 500 by roughly 9%. While that’s good news, it’s not the reason I’m writing this article. What is even more significant is that this rally…

Read More

Bruker’s Q2 2023 Triumph: Dominates Scientific Instrument Market Again (NASDAQ:BRKR)

Zorica Nastasic/E+ via Getty Images On August 3, 2023, Bruker Corporation (NASDAQ:BRKR), one of the leaders in the scientific instrument market, published its financial report for the second quarter of 2023. The company specializes in the design and manufacture of high-performance equipment, including for such areas as pharmaceuticals, life sciences research, and materials science research….

Read More

Sage Therapeutics’ Zuranolone Is A Lost Cause In Depression Market (NASDAQ:SAGE)

bymuratdeniz Introduction Sage Therapeutics (NASDAQ:SAGE) is a biopharmaceutical company with a specialization in brain health medications. They focus on treating disorders such as depression, neurology, and neuropsychiatry by targeting the central nervous system’s GABA and NMDA receptor systems. With products like Zulresso (intravenous brexanolone) for postpartum depression, Sage continues to advance in the field by…

Read More

Builders FirstSource: Ideally Positioned To Benefit From U.S. Housing Shortage (NYSE:BLDR)

halbergman Company Presentation Founded in 1998 and based in Dallas, Texas, Builders FirstSource (NYSE:BLDR) is a leading supplier of building materials and construction services in the United States. BLDR operates a network of distribution centers and manufacturing facilities across the country, serving customers in the residential construction, remodeling, and commercial construction markets. The firm operates…

Read More

Cincinnati Financial: Robust Quarterly Performance Driven By Investment Gain (NASDAQ:CINF)

MicroStockHub Executive Summary Cincinnati Financial (NASDAQ:CINF) recently released its quarterly results, showing an impressive turnaround in net income from a $818 million loss in the previous year to a profit of $534 million. Year-to-date post-tax profit also rose significantly by $1.8 billion to reach $759 million, mainly due to unrealized equity gains, in contrast to…

Read More

Dollar Comes Back Bid | Seeking Alpha

mirza kadic Overview The US dollar is recovering today after it was sold following the jobs report before the weekend. It is enjoying a firmer bias against nearly all the G10 currencies. The dollar bloc is faring best, while the Scandis are off close to 0.5%. Most emerging market currencies are also softer, with only…

Read More

EOG Resources: Another Strong Production Quarter

grandriver/iStock via Getty Images Part I – Introduction Houston-based EOG Resources, Inc. (NYSE:EOG) released its second quarter 2023 results on August 3, 2023. Important note: This article updates my preceding article, published on July 11, 2023. I have followed EOG on Seeking Alpha since 2016. EOG Resources produces from five Premium Basins and is a…

Read More

Generation Bio: Novel But Preclinical, Interesting But Without Data (NASDAQ:GBIO)

byakkaya Generation Bio (NASDAQ:GBIO) says it is a global leader in non-viral DNA therapeutics. Their goal is to “deliver lifelong, titratable gain of function genetic medicines on a disruptive global scale.” The company has 3 core technologies, described in their 10-K as follows: Our non-viral genetic medicine platform is comprised of three essential component technologies:…

Read More

Constellium: Benefiting From The Strong Market Position And Pricing Power (NYSE:CSTM)

Bet_Noire/iStock via Getty Images Constellium (NYSE:CSTM) is experiencing a downturn in revenue growth, which is driven mainly by packaging end-market weakness. However, the company is coping relatively well due to its pricing power and ability to exploit more successfully the momentum in the aerospace market. In addition, Constellium streamlined its business model in order to…

Read More

Kohl’s Is The Turnaround Play Of 2023 (NYSE:KSS)

Bruce Bennett Background The world of stand-alone, physical retail is brutal. The multi-decade transition of shopping habits by consumers from in-person buying to e-commerce has left in its wake countless retailers who have failed to adapt to the new reality of how consumers shop. Some of the strongest players in the space remain, albeit somewhat…

Read More